Exicure, Inc. (XCUR)
1.31
+0.02
(+1.55%)
USD |
NASDAQ |
Aug 31, 16:00
1.26
-0.05
(-3.82%)
After-Hours: 20:00
Exicure Free Cash Flow : -6.385M for June 30, 2026
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2026 | -6.385M |
| March 31, 2026 | -8.10M |
| December 31, 2025 | -8.556M |
| September 30, 2025 | -8.467M |
| June 30, 2025 | -5.494M |
| March 31, 2025 | -4.058M |
| December 31, 2024 | -2.91M |
| September 30, 2024 | -2.881M |
| June 30, 2024 | -3.844M |
| March 31, 2024 | -7.489M |
| December 31, 2023 | -10.36M |
| September 30, 2023 | -16.82M |
| June 30, 2023 | -21.95M |
| March 31, 2023 | -26.22M |
| December 31, 2022 | -36.17M |
| September 30, 2022 | -43.04M |
| Date | Value |
|---|---|
| June 30, 2022 | -31.69M |
| March 31, 2022 | -34.02M |
| December 31, 2021 | -35.79M |
| September 30, 2021 | -33.55M |
| June 30, 2021 | -46.98M |
| March 31, 2021 | -49.05M |
| December 31, 2020 | -42.44M |
| September 30, 2020 | -15.83M |
| June 30, 2020 | -12.56M |
| March 31, 2020 | -4.169M |
| December 31, 2019 | 0.235M |
| September 30, 2019 | -20.47M |
| June 30, 2019 | -19.30M |
| March 31, 2019 | -18.95M |
| December 31, 2018 | -19.58M |
| September 30, 2018 | -19.13M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Tenax Therapeutics, Inc. | -46.03M |
| Manhattan Scientifics, Inc. | -- |
| Century Therapeutics, Inc. | -88.07M |
| Absci Corp. | -108.97M |
| Celularity, Inc. | -13.25M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -0.887M |
| Free Cash Flow Per Share (Quarterly) | -0.1392 |
| Free Cash Flow to Equity (Quarterly) | -0.865M |
| Free Cash Flow to Firm (Quarterly) | -0.887M |
| Free Cash Flow Yield | -76.62% |